ArcherDX
is a bioinformatics company that develops and commercializes NGS-based gene fusion detection assays for oncology applications... Read moreArcherDX
is a bioinformatics company that develops and commercializes NGS-based gene fusion detection assays for oncology applications... Read more
News
Dec 21, 2022
BizWest
ArcherDX: Integrated DNA Technologies absorbs ArcherDX tech, Boulder facility in Invitae firesale
Oct 05, 2020
The Business Journals: Denver
ArcherDX: Invitae completes its $1.4B acquisition of Boulder-based ArcherDX
Oct 05, 2020
360DX
ArcherDX: Federal Court Rejects ArcherDx Motion Against Natera in Patent Infringement Lawsuit
Oct 05, 2020
BioSpace
ArcherDX: Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
Sep 17, 2020
ArcherDX Blog
ArcherDX Blog ArcherDX to Present at Cowen’s 2020 Liquid Biopsy Summit
Sep 08, 2020
ArcherDX Blog
ArcherDX Blog ArcherDX to Participate in Morgan Stanley 18th Annual Global Healthcare Conference
Aug 11, 2020
ArcherDX Blog
ArcherDX Blog UBS Genomics 2.0 and Medtech Innovations Virtual Summit Webcast Link
Aug 07, 2020
Micro Small Cap
ArcherDX: Natera Files Additional Suit Against ArcherDX
Aug 05, 2020
ArcherDX Blog
ArcherDX Blog ArcherDX to Participate in UBS Genomics 2.0 and Medtech Innovations Virtual Summit
Aug 02, 2020
InnovationNews
ArcherDX: ArcherDX and UCL extend TRACERx program collaboration to evaluate cancer evolution
ArcherDX Competitors
1
2
3
4
5
6
7
8
9
10